SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts -- Ignore unavailable to you. Want to Upgrade?


To: The SPHINX who wrote (13116)3/9/1999 1:09:00 PM
From: Joe Copia  Read Replies (1) | Respond to of 25711
 
excerpt from ZKEM news:

"Preliminary studies have shown strong anti-neoplastic efficacy of these compounds against a wide array of cancer tumor cells and leukemic cells rivaling, and in certain instances, significantly outperforming paclitaxel (marketed by Bristol-Myers Squibb under its Taxol® trademark) and Rhone Poulenc Rohrer's Taxotere® analog.

Joe PTG&LI !!!